ABBOTT LABORATORIES — Investor Relations & Filings
Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of life-changing technologies. The company's operations are focused on four core businesses: Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals. The Medical Devices division offers solutions for cardiovascular health, diabetes care (including the FreeStyle Libre continuous glucose monitoring system), and neuromodulation. The Diagnostics segment provides a wide range of in vitro diagnostic systems and tests for hospitals, laboratories, and clinics. The Nutrition business develops and markets science-based nutritional products for people of all ages, with leading brands such as Similac, PediaSure, Ensure, and Glucerna. The Established Pharmaceuticals division provides a portfolio of branded generic medicines to consumers in emerging markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-8 - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-24 | English | |
| 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-17 | English | |
| 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-16 | English | |
| SCHEDULE 13G/A - ABBOTT LABORATORIES (0000001800) (Subject) | 2026-03-26 | English | |
| 4 - ABBOTT LABORATORIES (0000001800) (Issuer) | 2026-03-25 | English | |
| 3 - ABBOTT LABORATORIES (0000001800) (Issuer) | 2026-03-25 | English |
Browse filings by year
33 years- 2026 40 filings
- 2025 85 filings
- 2024 75 filings
- 2023 107 filings
- 2022 115 filings
- 2021 147 filings
- 2020 146 filings
- 2019 143 filings
- 2018 139 filings
- 2017 181 filings
- 2016 263 filings
- 2015 271 filings
- 2014 242 filings
- 2013 484 filings
- 2012 179 filings
- 2011 175 filings
- 2010 217 filings
- 2009 237 filings
- 2008 192 filings
- 2007 196 filings
- 2006 152 filings
- 2005 114 filings
- 2004 120 filings
- 2003 50 filings
- 2002 26 filings
- 2001 34 filings
- 2000 17 filings
- 1999 29 filings
- 1998 24 filings
- 1997 12 filings
- 1996 17 filings
- 1995 8 filings
- 1994 9 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 36260641 | S-8 - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-24 | English | ||
| 34661940 | 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-17 | English | ||
| 34647007 | 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-16 | English | ||
| 33051650 | SCHEDULE 13G/A - ABBOTT LABORATORIES (0000001800) (Subject) | 2026-03-26 | English | ||
| 33043414 | 4 - ABBOTT LABORATORIES (0000001800) (Issuer) | 2026-03-25 | English | ||
| 33043382 | 3 - ABBOTT LABORATORIES (0000001800) (Issuer) | 2026-03-25 | English | ||
| 33016698 | S-8 - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-03-23 | English | ||
| 33013457 | 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-03-23 | English | ||
| 32874359 | 4 Filing | 2026-03-04 | English | ||
| 32874360 | 4 Filing | 2026-03-04 | English | ||
| 32874361 | 4 Filing | 2026-03-04 | English | ||
| 32874362 | 4 Filing | 2026-03-04 | English | ||
| 32874363 | 4 Filing | 2026-03-04 | English | ||
| 32874364 | 4 Filing | 2026-03-04 | English | ||
| 32874365 | 4 Filing | 2026-03-04 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
cbdMD, Inc.
Producer and distributor of health and wellness CBD product…
|
YCBD | US | Manufacturing |
|
CDT Equity Inc.
A clinical-stage biopharmaceutical firm advancing assets fo…
|
CDT | US | Manufacturing |
|
Ceapro Inc.
Develops and commercializes natural active ingredients deri…
|
CZO | CA | Manufacturing |
|
CELADON PHARMACEUTICALS PLC
Researches, cultivates, and manufactures cannabinoid-based …
|
CEL | GB | Manufacturing |
|
Celemics, Inc.
Develops NGS target enrichment solutions for research and c…
|
331920 | KR | Manufacturing |
|
Cellbion Co., Ltd
Develops radiopharmaceuticals and radioligand therapies for…
|
308430 | KR | Manufacturing |
|
CELL BIOTECH CO ., LTD
Develops and manufactures probiotic solutions using patente…
|
049960 | KR | Manufacturing |
|
Celldex Therapeutics, Inc.
Develops antibody-based immunotherapies for severe inflamma…
|
CLDX | US | Manufacturing |
|
Cellectar Biosciences, Inc.
Clinical-stage biopharma developing targeted cancer treatme…
|
CLRB | US | Manufacturing |
|
Cellectis
Develops allogeneic, or 'off-the-shelf', CAR T-cell immunot…
|
ALCLS | FR | Manufacturing |
ABBOTT LABORATORIES via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/29777/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=29777 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=29777 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=29777 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 29777}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ABBOTT LABORATORIES (id: 29777)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.